v3.26.1
Stock-Based Compensation - Additional Information (Details)
3 Months Ended 6 Months Ended
Jun. 10, 2026
shares
Mar. 11, 2026
$ / shares
shares
Feb. 19, 2026
$ / shares
shares
Feb. 17, 2026
USD ($)
$ / shares
shares
Jun. 16, 2025
Jun. 30, 2026
USD ($)
shares
Mar. 31, 2026
USD ($)
shares
Jun. 30, 2025
shares
Jun. 30, 2026
USD ($)
$ / shares
shares
Jun. 30, 2025
USD ($)
Jan. 01, 2027
shares
Apr. 10, 2026
shares
Jun. 15, 2025
shares
Feb. 28, 2021
shares
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                            
Stock options exercised | $           $ 98,000 $ 1,033,000     $ 0        
Weighted average fair value per share of options granted | $ / shares                 $ 21.04          
Aggregate intrinsic value of stock options exercised | $                 $ 2,200,000          
Grant date fair value of options vested | $                 1,100,000 $ 700,000        
Unrecognized stock-based compensation expense | $           62,200,000     $ 62,200,000          
Weighted-average period                 3 years 6 months 29 days          
Options available for grant                 3,107,976          
Weighted-Average Exercise Price, Granted | $ / shares                 $ 27.06          
Exercise of options into common stock, shares                 134,185          
Fair value of assumed options | $       $ 500,000                    
Maximum                            
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                            
Unrecognized compensation expense remaining service period       3 years 6 months                    
Minimum                            
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                            
Exercise price per share | $ / shares       $ 1.16                    
Unrecognized compensation expense remaining service period       1 month 6 days                    
Common Stock Warrants                            
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                            
Unrecognized stock-based compensation expense | $           $ 0     $ 0          
Common Stock                            
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                            
Number of shares issued               1,004            
Exercise of options into common stock, shares           57,042 77,143              
Exchange ratio       0.1993%                    
Common Stock | Maximum                            
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                            
Exercise price per share | $ / shares       $ 5.22                    
Faeth Therapeutics LLC                            
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                            
Exercise of options into common stock, shares       6,338,670                    
Employees vesting options       4,273,182                    
Research and development expenses related to accelerated vesting options | $       $ 4,800,000         4,800,000          
General and administrative expenses related to accelerated vesting options | $       $ 6,200,000         $ 6,200,000          
Faeth Therapeutics LLC | Common Stock                            
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                            
Common Stock, Converted in to Options to Purchase Common Stock       252,210                    
Restricted Stock Units                            
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                            
Weighted-average period                 7 months 17 days          
Employees vesting options                 1,505          
2021 Equity Incentive Plan | Restricted Stock Units | Vesting Period One                            
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                            
Vesting period                 1 year          
2021 Equity Incentive Plan | Restricted Stock Units | Vesting Period Two                            
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                            
Vesting period                 2 years          
2021 Equity Incentive Plan | Restricted Stock Units | Vesting Period Three                            
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                            
Vesting period                 3 years          
2021 Equity Incentive Plan | Restricted Stock Units | Vesting Period Four                            
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                            
Vesting period                 4 years          
2026 Equity Incentive Plan                            
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                            
Shares reserved for issuance           2,376,981     2,376,981          
Number of capital stock outstanding percentage                 5.00%          
2026 Equity Incentive Plan | Forecast                            
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                            
Shares reserved for issuance                     2,671,981      
2021 Employee Stock Purchase Plan                            
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                            
Shares reserved for issuance                         333,333 16,666
Shares issued under plan                 12,220          
Number of shares issued                 0          
Reverse stock split ratio         0.05                  
2026 Employee Stock Purchase Plan                            
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                            
Shares reserved for issuance 267,198                          
Percentage of number of shares of capital stock outstanding on last day of preceding year 1.00%                          
Purchase price of fair value common stock, percent 85.00%                          
Shares issued under plan 534,396               0          
2026 Inducement Plan                            
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                            
Shares reserved for issuance           250,350     250,350     450,000    
Options available for grant                 199,650          
Inducement Grants                            
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                            
Options available for grant   166,435 2,319,891                      
Weighted-Average Exercise Price, Granted | $ / shares   $ 29.37 $ 27.22                      
Vesting period                 4 years          
Inducement Grants | Vesting Period One                            
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                            
Vesting period                 1 year          
Vesting (as a percent)                 25.00%          
Inducement Grants | Vesting Period Two                            
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                            
Vesting period                 3 years          
Vesting (as a percent)                 75.00%